By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Abeille Pharmaceuticals, Inc. 

116 Village Boulevard
Suite 200
Princeton  New Jersey  08540-5799  U.S.A.
Phone: 609-951-2204 Fax: 609-951-2223


Key Statistics

Ownership: Private

Web Site: Abeille Pharma


Company News
Abeille Pharmaceuticals, Inc. Licenses AB-1001 to SymBio Pharmaceuticals for Commercialization in Japan and Pacific Rim Countries 3/15/2007 10:49:33 AM
Abeille Pharmaceuticals, Inc. Submits AB-1001 Phase III Pivotal Efficacy Study Protocol For FDA Review 8/9/2006 10:21:19 AM
Abeille Pharmaceuticals, Inc. In-Licenses Worldwide Exclusive Rights To Technology For Transdermal Patch Applications 5/3/2006 12:14:45 PM
Abeille Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of AB-1001 For Prevention Of Emesis Associated With Chemo- And Radiation Therapy 2/1/2006 10:34:14 AM
Abeille Pharmaceuticals, Inc. Appoints Scientific Advisory Committee 11/14/2005 11:16:13 AM
Abeille Pharmaceuticals, Inc. Completes $1.0 Million Preferred Stock Financing; Company To Advance Development Of Lead Products, Enhance Pipeline10/19/2005 5:12:47 PM
Abeille Pharmaceuticals, Inc. Appoints Two New Members To The Board Of Directors10/19/2005 5:09:43 PM